This association is corroborated by experimental observations of the presence of balanced, moderate levels of active Rac1 and RhoA in cells of the hybrid E/M phenotype not only during cancer metastasis (type III EMT), but also during wound healing (type II EMT), and embryonic development (type I EMT)26, 27, 28. This evidence concerns the gene RAC1 and cancer.